0
13

In This Issue
  |  
The American Journal of Psychiatry

January 01, 1999, Vol. 156, No. 1
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Editorial
Science is Revolutionizing Our View of Addiction—and What to Do About It
ALAN I. LESHNER, PH.D.
Special Article
Treatment Research at the Crossroads: The Scientific Interface of Clinical Trials and Effectiveness Research
Kenneth B. Wells, M.D., M.P.H.
Regular Article
Limbic Activation During Cue-Induced Cocaine Craving
Anna Rose Childress, Ph.D.; P. David Mozley, M.D.; William McElgin, B.A.; Josh Fitzgerald, B.A.; Martin Reivich, M.D.; Charles P. O’Brien, M.D., Ph.D.
Association of Methylphenidate-Induced Craving With Changes in Right Striato-orbitofrontal Metabolism in Cocaine Abusers: Implications in Addiction
Nora D. Volkow, M.D.; Gene-Jack Wang, M.D.; Joanna S. Fowler, Ph.D.; Robert Hitzemann, Ph.D.; Burton Angrist, M.D.; Samuel J. Gatley, Ph.D.; Jean Logan, Ph.D.; Yu-Shin Ding, Ph.D.; Naomi Pappas, M.S.
Day Treatment Versus Enhanced Standard Methadone Services for Opioid-Dependent Patients: A Comparison of Clinical Efficacy and Cost
S. Kelly Avants, Ph.D.; Arthur Margolin, Ph.D.; Jody L. Sindelar, Ph.D.; Bruce J. Rounsaville, M.D.; Richard Schottenfeld, M.D.; Susan Stine, M.D., Ph.D.; Ned L. Cooney, Ph.D.; Robert A. Rosenheck, M.D.; Shou-Hua Li, Ph.D.; Thomas R. Kosten, M.D.
Genetic and Environmental Contributions to Alcohol Abuse and Dependence in a Population-Based Sample of Male Twins
Carol A. Prescott, Ph.D.; Kenneth S. Kendler, M.D.
Clinical Implications for Four Drugs of the DSM-IV Distinction Between Substance Dependence With and Without a Physiological Component
Marc A. Schuckit, M.D.; Jean-Bernard Daeppen, M.D.; George P. Danko, Ph.D.; Megan L. Tripp, B.A.; Tom L. Smith, Ph.D.; Ti.-K. Li, M.D.; Victor M. Hesselbrock, Ph.D.; Kathleen K. Bucholz, Ph.D.
Prospective Study of Risk Factors for Alzheimer’s Disease: Results at 7.5 Years
George S. Zubenko, M.D., Ph.D.; Ethel Winwood, R.N.; Barbara Jacobs, B.S.N., M.Ed.; Ivana Teply, M.S.; J. Scott Stiffler, B.S.; Hugh B. Hughes III, M.S.; F. Jacob Huff, M.D.; Trey Sunderland, M.D.; A. Julio Martinez, M.D.
Cognitive Decline in Adulthood: An 11.5-Year Follow-Up of the Baltimore Epidemiologic Catchment Area Study
Constantine G. Lyketsos, M.D., M.H.S.; Li-Shiun Chen, M.D., M.P.H.; James C. Anthony, Ph.D.
Physical Aggression in Dementia Patients and Its Relationship to Depression
Constantine G. Lyketsos, M.D., M.H.S.; Cynthia Steele, R.N., M.P.H.; Elizabeth Galik, R.N., M.S.N.; Adam Rosenblatt, M.D.; Martin Steinberg, M.D.; Andrew Warren, M.B.B.S.; Jeannie-Marie Sheppard, B.A.
Serotonin 5-HT2 Receptors in Schizophrenia: A PET Study Using [18F]Setoperone in Neuroleptic-Naive Patients and Normal Subjects
Ralph Lewis, M.D., F.R.C.P.C.; Shitij Kapur, M.D., Ph.D., F.R.C.P.C.; Corey Jones, B.Sc.; Jean DaSilva, Ph.D.; Gregory M. Brown, M.D., Ph.D., F.R.C.P.C.; Alan A. Wilson, Ph.D.; Sylvain Houle, M.D., Ph.D., F.R.C.P.C.; Robert B. Zipursky, M.D., F.R.C.P.C.
Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis
Todd M. Sanger, Ph.D.; Jeffery A. Lieberman, M.D.; Mauricio Tohen, M.D., Dr.P.H.; Starr Grundy, B.Sc.Pharm.; Charles Beasley, Jr., M.D.; Gary D. Tollefson, M.D., Ph.D.
Impact of Clozapine on Negative Symptoms and on the Deficit Syndrome in Refractory Schizophrenia
Robert Rosenheck, M.D.; Lawrence Dunn, M.D.; Michael Peszke, M.D.; Joyce Cramer; Weichun Xu, Ph.D.; Jonathan Thomas, M.S.; Dennis Charney, M.D.; the Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia
Measuring Desire for Death Among Patients With HIV/AIDS:The Schedule of Attitudes Toward Hastened Death
Barry Rosenfeld, Ph.D.; William Breitbart, M.D.; Kelly Stein, M.A., M.Ed.; Julie Funesti-Esch, R.N.; Monique Kaim, Ph.D.; Suzanne Krivo, B.A.; Michele Galietta, M.A.
Fluoxetine Treatment for Depression in Patients With HIV and AIDS: A Randomized, Placebo-Controlled Trial
Judith G. Rabkin, Ph.D., M.P.H.; Glenn J. Wagner, Ph.D.; Richard Rabkin, M.D.
Earnings Changes for Depressed Individuals Treated by Mental Health Specialists
Mingliang Zhang, Ph.D.; Kathryn M. Rost, Ph.D.; John C. Fortney, Ph.D.
Past-Year Use of Outpatient Services for Psychiatric Problems in the National Comorbidity Survey
Ronald C. Kessler, Ph.D.; Shanyang Zhao, Ph.D.; Steven J. Katz, M.D., M.P.H.; Anthony C. Kouzis, Ph.D.; Richard G. Frank, Ph.D.; Mark Edlund, Ph.D.; Philip Leaf, Ph.D.
Clinical Case Conference
Long-Term Care of an Individual With Schizophrenia: Pharmacologic, Psychological, and Social Factors
Kenneth S. Kendler, M.D.
Brief Report
Low CSF Concentration of a Dopamine Metabolite in Tobacco Smokers
Thomas D. Geracioti, Jr., M.D.; Scott A. West, M.D.; Dewleen G. Baker, M.D.; Kelly K. Hill, M.D.; Nosa N. Ekhator, M.S.; Matthew D. Wortman, B.S.; Paul E. Keck, Jr., M.D.; Andrew B. Norman, Ph.D.
Adolescent Depressive Symptoms as Predictors of Adult Depression: Moodiness or Mood Disorder?
Daniel S. Pine, M.D.; Elizabeth Cohen, B.A.; Patricia Cohen, Ph.D.; Judith Brook, Ed.D.
Genetic Association Analysis of Serotonin System Genes in Bipolar Affective Disorder
John B. Vincent, Ph.D.; Mario Masellis, M.Sc.; Jacob Lawrence, M.B., B.S., M.R.C.Psych.; Victor Choi, B.Sc.; Hugh M.D. Gurling, M.D., M.Phil., F.R.C.Psych.; Sagar V. Parikh, M.D.; James L. Kennedy, M.D.
Frontosubcortical Neuroanatomy and the Continuous Performance Test in Mania
Kenji W. Sax, Ph.D.; Stephen M. Strakowski, M.D.; Molly E. Zimmerman, B.A.; Melissa P. DelBello, M.D.; Paul E. Keck, Jr., M.D.; John M. Hawkins, M.D.
Intramuscular Flunitrazepam Versus Intramuscular Haloperidol in the Emergency Treatment of Aggressive Psychotic Behavior
Abraham Dorevitch, Pharm.D.; Nachum Katz, M.D.; Zvi Zemishlany, M.D.; Dov Aizenberg, M.D.; Abraham Weizman, M.D.
Effect of Clozapine and Adjunctive High-Dose Glycine in Treatment-Resistant Schizophrenia
Steven G. Potkin, M.D.; Yi Jin, M.D.; Blynn G. Bunney, Ph.D.; Jerome Costa, M.D.; Bala Gulasekaram, M.D.
Letters to the Editor
Enhancing the Tolerability of Tacrine With Propantheline
RAYMOND A. FABER, M.D.; PAULO J. NEGRO, M.D.
Sildenafil Citrate for SSRI-Induced Sexual Side Effects
JAMES L. SCHALLER, M.D., M.A.R.; DAVID BEHAR, M.D.
Letters to the Editor
KENNETH PAUL ROSENBERG, M.D.
Possible Hazard in Use of Priming Dose to Determine Lithium Dosage
JAN WILLEM PETERSE, M.D.; JOHAN M. HAVENAAR, M.D., PH.D.; HERMAN J.M. VAN RIJN, M.D., PH.D.
Case Vignette in a Community-Based Study
S.M. RAZALI, M.D.; A.M. HAMZAH, M.D., M.P.H.
British Experience With High-Dose Olanzapine for Treatment-Refractory Schizophrenia
CHRISTOPHER Q. MOUNTJOY, M.B., B.S., F.R.C.PSYCH.; ALEXANDER M. BALDACCHINO, M.D., M.R.C.PSYCH., M.PHIL.; JEAN H. STUBBS, M.SC., M.R.PHARM.S.
Fluoxetine Versus Phenelzine in Obsessive- Compulsive Disorder
DANIEL H. GOLWYN, M.D.; CAROL P. SEVLIE, M.S.N., A.R.N.P., C.N.S.
Dr. Jenike and Colleagues Reply
MICHAEL A. JENIKE, M.D.; LEE BAER, PH.D.; WILLIAM E. MINICHIELLO, ED.D.; SCOTT L. RAUCH, M.D.; M. LYNN BUTTOLPH, M.D., PH.D.
Treatment-Refractory Catatonia, ECT, and Parenteral Lorazepam
SCOTT C. ARMSTRONG, M.D.
Letters to the Editor
RALPH J. KOEK, M.D.; J. RANDY MERVIS, M.D.
Dr. Boronow and Colleagues Reply
JOHN J. BORONOW, M.D.; ANNE M. STOLINE, M.D.; STEVEN S. SHARFSTEIN, M.D.
Book Forum: HEALTH ECONOMICS AND OUTCOME MEASURES
Managing Managed Care
HAROLD J. BURSZTAJN, M.D.
Mental Health Practice in Geriatric Health Care Settings
CATHERINE L. WOODMAN, M.D.
Mental Health Outcome Measures
DARREL A. REGIER, M.D., M.P.H.
Outcomes Assessment in Clinical Practice
WILLIAM R. FLYNN, M.D.
Book Forum: CHILD PSYCHIATRY AND DEVELOPMENTAL DISORDERS
Diagnosis and Psychopharmacology of Childhood and Adolescent Disorders, 2nd ed.
GABRIELLE A. CARLSON, M.D.; FARHEEN FAHIM, M.D.
The Lifespan Development of Individuals: Behavioral, Neurobiological, and Psychosocial Perspectives: A Synthesis
LAURA A. FLASHMAN, PH.D.
Language, Learning, and Behavior Disorders: Developmental, Biological, and Clinical Perspectives
J. BRUCE TOMBLIN, PH.D.
Book Forum: SUBSTANCE USE AND ABUSE
Drugs, the Brain, and Behavior: The Pharmacology of Abuse and Dependence
PHILIP E. VEENHUIS, M.D., M.P.H.
The Chemistry of Mind-Altering Drugs: History, Pharmacology, and Cultural Context
RICK J. STRASSMAN, M.D.
The Genetics of Alcoholism
MICHELLE KIM LEFF, M.D.
Images In Neuroscience
Brain Development, IX: Human Brain Growth
JAY GIEDD, M.D.
Images in Psychiatry
Prethymoleptic Use of Lithium
RIF S. EL-MALLAKH, M.D.; JAMES W. JEFFERSON, M.D.
Book Forum: WOMEN’S HEALTH
Women’s Health: Hormones, Emotions, and Behavior
MARY V. SEEMAN, M.D.
Women and Group Psychotherapy: Theory and Practice
NADA L. STOTLAND, M.D.
  |  
Copyright ©
American
Psychiatric
Association